Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk

Journal of Steroid Biochemistry and Molecular Biology

Volumn 106, Issue 1-5, 2007, Pages 24-30

  Hankinson, Susan E ^a,b   Eliassen, A Heather ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast cancer; Epidemiology; Estrogens; Postmenopausal; Premenopausal; Prospective; Testosterone

Indexed keywords

ESTROGEN; PROGESTERONE; TESTOSTERONE;

ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; ESTROGEN BLOOD LEVEL; HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PROGESTERONE BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL;

ANIMALS; BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; PREMENSTRUAL SYNDROME; PROGESTERONE; RISK FACTORS; TESTOSTERONE;

EID: 34548474900     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.05.012     Document Type: Article

References (51)

1. Hankinson S.E., Colditz G.A., and Willett W.C. Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle and hormones. Breast Cancer Res. 6 (2004) 213-218
2. van den Brandt P.A., Spiegelman D., Yaun S.S., Adami H.O., Beeson L., Folsom A.R., Fraser G., et al. Pooled analysis of prospective cohort studies on height, weight and breast cancer risk. Am. J. Epidemiol. 152 (2000) 514-527
3. Cuzick J., Powles T., Veronesi U., Forbes J., Edwards R., Ashley S., and Boyle P. Overview of the main outcomes in breast-cancer prevention trials. Lancet 361 (2003) 296-300
4. Baum M., Budzar A.U., Cuzick J., Forbes J., Houghton J.H., Klijn J.G., and Sahmoud T. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 359 (2002) 2131-2139
5. Henderson B.E., and Feigelson H.S. Hormonal carcinogenesis. Carcinogenesis 21 (2000) 427-433
6. Liao D.J., and Dickson R.B. Roles of androgens in the development, growth and carcinogenesis of the mammary gland. J. Steroid Biochem. Mol. Biol. 80 (2002) 175-189
7. Lanari C., and Molinolo A.A. Progesterone receptors: animal models and cell signaling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer. Breast Cancer Res. 4 (2002) 240-243
8. Campagnoli C., Clavel-Chapelon F., Kaaks R., Peris C., and Berrino F. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J. Steroid Biochem. Mol. Biol. 96 B (2005) 95-108
9. Toniolo P., Koenig Pasternack B.S., Banerjee S., Rosenberg C., Shore R.E., Strax P., and Levitz M. Reliability of measurements of total, protein-bound and unbound estradiol in serum. Cancer Epidemiol. Biomarkers Prev. 3 (1994) 47-50
10. Hankinson S.E., Manson J.E., Spiegelman D., Willett W.C., Longcope C., and Speizer F.E. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 649-654
11. Micheli A., Muti P., Pisani P., Secreto G., Recchione C., Totis A., Fissi R., et al. Repeated serum and urinary androgen measurements in premenopausal and postmenopausal women. J. Clin. Epidemiol. 44 (1991) 1055-1061
12. Muti P., Trevisan M., Micheli A., Krogh V., Bolelli G., Sciajno R., and Berrino F. Reliability of serum hormones in premenopausal and postmenopausal women over a 1-year period. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 917-922
13. Missmer S.A., Spiegelman D., Bertone-Johnson E.R., Barbieri R.L., Pollak M.N., and Hankinson S.E. Reproductibility of plasma hormone and growth factor levels among premenopausal women over a 2-3-year period. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 972-978
14. Michaud D.S., Manson J.E., Spiegelman D., Barbieri R.L., Sepkovic D.W., Bradlow H.L., and Hankinson S.E. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a 1-year period. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 1059-1064
15. Willett W.C. Nutritional Epidemiology (1998), Oxford University Press, New York
16. van Landeghem A.A., Poortman J., Nabuurs M., and Thijssen J.H. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 45 (1985) 2900-2906
17. Thijssen J.H., Blankenstein M.A., Miller W.R., and Milewicz A. Estrogens in tissues: uptake from the peripheral circulation or local production. Steroids 50 (1987) 297-306
18. Vermeulen A., Deslypere J.P., Paridaens R., Leclercq G., Roy F., Heuson J.C., and Aromatase. 17-β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women. Eur. J. Cancer Clin. Oncol. 22 (1986) 515-525
19. Recchione C., Venturelli E., Manzari A., Cavalleri A., Martinetti A., and Secreto G. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues. J. Steroid Biochem. Mol. Biol. 52 (1995) 541-546
20. Mady E.A., Ramadan E.E., and Ossman A.A. Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients. Dis. Markers 16 (2000) 151-157
21. Key T., Appleby P., Barnes I., and Reeves G. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. 94 (2002) 606-616
22. Manjer J., Johansson R., Berglund G., Janzon L., Kaaks R., Agren A., and Lenner P. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer Causes Control 14 (2003) 599-607
23. Key T.J., Wang D.Y., Brown J.B., Hermon C., Allen D.S., Moore J.W., Bulbrook R.D., Fentiman I.S., and Pike M.C. A prospective study of urinary oestrogen excretion and breast cancer risk. Br. J. Cancer 73 (1996) 1615-1619
24. Onland-Moret N.C., Kaaks R., van Noord P.A., Rinaldi S., Key T., Grobbee D.E., and Peeters P.H. Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer. Br. J. Cancer 88 (2003) 1394-1399
25. Kaaks R., Rinaldi S., Key T.J., Berrino F., Peeters P.H., Biessy C., Dossus L., et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr. Relat. Cancer 12 (2005) 1071-1082
26. Zeleniuch-Jacquotte A., Shore R.E., Koenig K.L., Akhmedkhanov A., Afanasyeva Y., Kato I., Kim M.Y., et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br. J. Cancer 90 (2004) 153-159
27. Missmer S.A., Eliassen A.H., Barbieri R.L., and Hankinson S.E. Endogenous estrogen, androgen and progesterone concentrations and breast cancer risk among postmenopausal women. J. Natl. Cancer Inst. 96 (2004) 1856-1865
28. Beattie M.S., Costantino J.P., Cummings S.R., Wickerham D.L., Wolmark N., Dowsett M., Folkerd E.J., et al. Endogenous sex hormones, risk of breast cancer, and response to tamoxifen: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). JNCI (2006)
29. Eliassen A.H., Missmer S.A., Tworoger S.S., Spiegelman D., Barbieri R.L., Dowsett M., and Hankinson S.E. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J. Natl. Cancer Inst. 98 (2006) 1406-1415
30. Tworoger S.S., Missmer S.A., Barbieri R.L., Willett W.C., Colditz G.A., and Hankinson S.E. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. J. Natl. Cancer Inst. 97 (2005) 595-602
31. Fisher B., Costantino J.P., Wickerham D.L., Redmond C.K., Kavanah M., Cronin W.M., Vogel V., et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. Natl. Cancer Inst. 90 (1998) 1371-1388
32. Colditz G.A., and Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am. J. Epidemiol. 152 (2000) 950-964
33. Tyrer J., Duffy S.W., and Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat. Med. 23 (2004) 1111-1130
34. Freedman A.N., Seminara D., Gail M.H., Hartge P., Colditz G.A., Ballard-Barbash R., and Pfeiffer R.M. Cancer risk prediction models: a workshop on development, evaluation and application. J. Natl. Cancer Inst. 97 (2005) 715-723
35. Cummings S.R., Duong T., Kenyon E., Cauley J.A., Whitehead M., and Krueger K.A. Serum estradiol level and risk of breast cancer during treatment with raloxifene. J. Am. Med. Assoc. 287 (2002) 216-220
36. Wysowski D.K., Comstock G.W., Helsing K.J., and Lau H.L. Sex hormone levels in serum in relation to the development of breast cancer. Am. J. Epidemiol. 125 (1987) 791-799
37. Helzlsouer K.J., Alberg A.J., Bush T.L., Longcope C., Gordon G.B., and Comstock G.W. A prospective study of endogenous hormones and breast cancer. Cancer Detect. Prev. 18 (1994) 79-85
38. Rosenberg C.R., Pasternack B.S., Shore R.E., Koenig K.L., and Toniolo P.G. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am. J. Epidemiol. 140 (1994) 518-525
39. Thomas H.V., Key T.J., Allen D.S., Moore J.W., Dowsett M., Fentiman I.S., and Wang D.Y. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br. J. Cancer 75 (1997) 1075-1079
40. Kabuto M., Akiba S., Stevens R.G., Neriishi K., and Land C.E. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 575-579
41. Kaaks R., Berrino F., Key T., Rinaldi S., Dossus L., Biessy C., Secreto G., et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J. Natl. Cancer Inst. 97 (2005) 755-765
42. Micheli A., Muti P., Secreto G., Krogh V., Meneghini E., Venturelli E., Sieri S., Pala V., and Berrino F. Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int. J. Cancer 112 (2004) 312-318
43. Thomas H.V., Key T.J., Allen D.S., Moore J.W., Dowsett M., Fentiman I.S., and Wang D.Y. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. Br. J. Cancer 76 (1997) 401-405
44. Siiteri P.K., Schwarz B.E., Moriyama I., Ashby R., Linkie D., and MacDonald P.C. Estrogen binding in the rat and human. Adv. Exp. Med. Biol. 36 (1973) 97-112
45. Siiteri P.K. Extraglandular oestrogen formation and serum binding of oestradiol: relationship to cancer. J. Endocrinol. 89 (1981) 119P-129P (Suppl.)
46. Bulun S.E., Price T.M., Aitken J., Mahendroo M.S., and Simpson E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab. 77 (1993) 1622-1628
47. Ricketts D., Turnbull L., Ryall G., Bakhshi R., Rawson N.S., Gazet J.C., Nolan C., and Coombes R.C. Estrogen and progesterone receptors in the normal female breast. Cancer Res. 51 (1991) 1817-1822
48. Markopoulos C., Berger U., Wilson P., Gazet J.C., and Coombes R.C. Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br. Med. J. (Clin. Res. Ed. ) 296 (1988) 1349-1351
49. Yue W., Santner S.J., Masamura S., Wang J.P., Demers L.M., Hamilton C., and Santen R.J. Determinants of tissue estradiol levels and biologic responsiveness in breast tumors. Breast Cancer Res. Treat. 49 (1998) S33-S37 (Suppl. 1S1-7; discussion)
50. Gompel A., Somai S., Chaouat M., Kazem A., Kloosterboer H.J., Beusman I., Forgez P., Mimoun M., and Rostene W. Hormonal regulation of apoptosis in breast cells and tissues. Steroids 65 (2000) 593-598
51. Sabourin J.C., Martin A., Baruch J., Truc T.B., and Gompel A. P.Poitout, bcl-2 expression in normal breast tissue during the menstrual cycle. Int. J. Cancer 59 (1994) 1-6